Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.79%13.13M | 12.63M | 11.12M | 8.87%48.65M | 11.87M | 12.29M | 10.96%44.69M | -4.70%40.27M | 49.14%42.26M | 24.77%28.33M |
| Cost of revenue | 5.79%8.04M | 7.91M | 7.72M | 8.70%28.92M | 7.58M | 7.6M | 9.64%26.61M | 9.49%24.27M | 46.29%22.16M | 21.85%15.15M |
| Gross profit | 8.41%5.09M | 4.72M | 3.41M | 9.12%19.73M | 4.29M | 4.69M | 12.96%18.08M | -20.34%16.01M | 52.42%20.09M | 28.31%13.18M |
| Operating expense | -21.39%2.05M | 2.82M | 2.63M | 33.66%12.34M | 4.02M | 2.61M | -22.71%9.23M | 7.15%11.95M | 48.79%11.15M | 9.48%7.49M |
| Other operating expenses | 1.90%2.73M | --3.22M | --3.15M | 35.13%12.73M | --4.31M | --2.68M | -22.29%9.42M | 5.75%12.12M | 48.06%11.46M | 9.70%7.74M |
| Total other operating income | 938.46%675K | --407K | --528K | 109.52%383.27K | --294K | --65K | 6.65%182.93K | -44.71%171.52K | 25.80%310.21K | 16.91%246.59K |
| Operating profit | 45.84%3.04M | 1.9M | 781K | -16.50%7.39M | 276K | 2.08M | 117.95%8.85M | -54.62%4.06M | 57.19%8.94M | 65.88%5.69M |
| Net non-operating interest income (expenses) | 5.45%-156K | -159K | -162K | 23.76%-476.83K | -173K | -165K | -91.34%-625.43K | 3.04%-326.88K | 9.18%-337.12K | -28.67%-371.18K |
| Non-operating interest income | ---- | ---- | ---- | 103.87%218.08K | ---- | ---- | 49.52%106.97K | 107.07%71.54K | 122.52%34.55K | 243.82%15.53K |
| Non-operating interest expense | -5.45%156K | --159K | --162K | -5.12%694.91K | --173K | --165K | 83.83%732.4K | 7.20%398.42K | -3.89%371.67K | 31.98%386.71K |
| Net investment income | 138.32%246.65K | 3.04%103.5K | 35.08%100.45K | 27.32%74.36K | -20.52%58.41K | |||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -89.65%82.24K | -56.34%794.57K | 809.85%1.82M | |||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | -94.31%195.67K | 11.03%3.44M | 6,629.56%3.1M | 46.03K | |||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | 94.31%-195.67K | -11.03%-3.44M | -6,629.56%-3.1M | ---46.03K |
| Less:Write off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- |
| Other non-operating income (expenses) | -27.25%17.04K | -2.96%23.42K | -24.11%24.13K | 8.20%31.8K | 68.91%29.39K | |||||
| Income before tax | 50.26%2.88M | 1.74M | 619K | -16.04%7.17M | 103K | 1.92M | 15.79%8.54M | -41.47%7.38M | 73.33%12.6M | 111.87%7.27M |
| Income tax | 111.30%879K | 538K | 313K | 13.86%2.61M | 582K | 416K | -2.83%2.29M | -25.41%2.36M | 76.41%3.17M | 52.62%1.79M |
| Net income | 33.33%2M | 1.2M | 306K | -27.02%4.56M | -479K | 1.5M | 24.56%6.25M | -46.85%5.02M | 72.32%9.44M | 142.76%5.48M |
| Net income continuous operations | 33.33%2M | --1.2M | --306K | -27.02%4.56M | ---479K | --1.5M | 24.56%6.25M | -46.85%5.02M | 72.32%9.44M | 142.76%5.48M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 33.33%2M | 1.2M | 306K | -27.02%4.56M | -479K | 1.5M | 24.56%6.25M | -46.85%5.02M | 72.32%9.44M | 142.76%5.48M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 33.33%2M | 1.2M | 306K | -27.02%4.56M | -479K | 1.5M | 24.56%6.25M | -46.85%5.02M | 72.32%9.44M | 142.76%5.48M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 11.11%0.002 | 0.0012 | 0.0003 | -38.16%0.0047 | -0.0005 | 0.0018 | 25.10%0.0076 | -74.92%0.0061 | 257.56%0.0242 | 141.96%0.0068 |
| Diluted earnings per share | 11.11%0.002 | 0.0012 | 0.0003 | -38.16%0.0047 | -0.0005 | 0.0018 | 25.10%0.0076 | -74.61%0.0061 | 253.14%0.0239 | 141.96%0.0068 |
| Dividend per share | 0.0025 | 0.004 | 0 | 2.86%0.0054 | 0 | 0 | 6.06%0.0053 | 204.62%0.005 | 8.33%0.0016 | 9.09%0.0015 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.